StreetInsider.com News Articles

Form 4 Apogee Therapeutics, For: Jun 10 Filed by: HENDERSON MICHAEL THOMAS

Fri, 12 Jun 2026 17:05:00 -0400

si-local-file:///var/storage/secattach/20260612/26641945.html

Form 4 Apogee Therapeutics, For: Jun 10 Filed by: HENDERSON MICHAEL THOMAS

Fri, 12 Jun 2026 17:05:00 -0400

si-local-file:///var/storage/secattach/20260612/26641945.html

Form 8-K Apogee Therapeutics, For: Jun 09

Fri, 12 Jun 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260612/26641882.html

Form 8-K Apogee Therapeutics, For: Jun 09

Fri, 12 Jun 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260612/26641882.html

Form 4 Apogee Therapeutics, For: Jun 09 Filed by: Shah Nimish P

Thu, 11 Jun 2026 20:04:00 -0400

si-local-file:///var/storage/secattach/20260611/26637215.html

Form 4 Apogee Therapeutics, For: Jun 09 Filed by: Shah Nimish P

Thu, 11 Jun 2026 20:04:00 -0400

si-local-file:///var/storage/secattach/20260611/26637215.html

Form 4 Apogee Therapeutics, For: Jun 09 Filed by: Fairmount Funds Management LLC

Thu, 11 Jun 2026 20:04:00 -0400

si-local-file:///var/storage/secattach/20260611/26637220.html

Form 4 Apogee Therapeutics, For: Jun 09 Filed by: Fairmount Funds Management LLC

Thu, 11 Jun 2026 20:04:00 -0400

si-local-file:///var/storage/secattach/20260611/26637220.html

Form 4 Apogee Therapeutics, For: Jun 09 Filed by: McKenna Mark C.

Thu, 11 Jun 2026 20:03:00 -0400

si-local-file:///var/storage/secattach/20260611/26637214.html

Form 4 Apogee Therapeutics, For: Jun 09 Filed by: McKenna Mark C.

Thu, 11 Jun 2026 20:03:00 -0400

si-local-file:///var/storage/secattach/20260611/26637214.html

Form 4 Apogee Therapeutics, For: Jun 09 Filed by: Fox Jennifer A.

Thu, 11 Jun 2026 20:02:00 -0400

si-local-file:///var/storage/secattach/20260611/26637211.html

Form 4 Apogee Therapeutics, For: Jun 09 Filed by: Fox Jennifer A.

Thu, 11 Jun 2026 20:02:00 -0400

si-local-file:///var/storage/secattach/20260611/26637211.html

Form 4 Apogee Therapeutics, For: Jun 09 Filed by: JONES WILLIAM A JR

Thu, 11 Jun 2026 20:02:00 -0400

si-local-file:///var/storage/secattach/20260611/26637212.html

Form 4 Apogee Therapeutics, For: Jun 09 Filed by: JONES WILLIAM A JR

Thu, 11 Jun 2026 20:02:00 -0400

si-local-file:///var/storage/secattach/20260611/26637212.html

Form 4 Apogee Therapeutics, For: Jun 09 Filed by: Bollinger Lisa

Thu, 11 Jun 2026 20:00:00 -0400

si-local-file:///var/storage/secattach/20260611/26637210.html

Form 4 Apogee Therapeutics, For: Jun 09 Filed by: Bollinger Lisa

Thu, 11 Jun 2026 20:00:00 -0400

si-local-file:///var/storage/secattach/20260611/26637210.html

Apogee Therapeutics Inc (APGE) PT Raised to $97 at RBC Capital

Mon, 08 Jun 2026 05:19:37 -0400

RBC Capital analyst Brian Abrahams raised the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $97.00 (from $82.00) while maintaining a Sector Perform rating.

The analyst comments "To gauge potential future use now that recent Part B data better clarified zumi's competitive profile in AD, we conducted a flash post-data survey of dermatologists, which revealed slightly higher-than-expected potential switch expectations but lower-than-expected use in biologics- naives. The results improve our confidence in our $2.5B out-year U.S. AD ests. and between that and the recent strong data, we are taking up our PoS and valuation (to $97 from $82), though we

Apogee Therapeutics Inc (APGE) PT Raised to $97 at RBC Capital

Mon, 08 Jun 2026 05:19:37 -0400

RBC Capital analyst Brian Abrahams raised the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $97.00 (from $82.00) while maintaining a Sector Perform rating.

Form 4 Apogee Therapeutics, For: Jun 03 Filed by: Dambkowski Carl

Fri, 05 Jun 2026 20:00:00 -0400

si-local-file:///var/storage/secattach/20260605/26612662.html

Form 4 Apogee Therapeutics, For: Jun 03 Filed by: Dambkowski Carl

Fri, 05 Jun 2026 20:00:00 -0400

si-local-file:///var/storage/secattach/20260605/26612662.html

Apogee Therapeutics Inc (APGE) PT Lowered to $116 at Deutsche Bank

Wed, 03 Jun 2026 07:14:25 -0400

Deutsche Bank analyst David Hoang lowered the price target on Apogee Therapeutics Inc (NASDAQ: APGE) to $116.00 (from $118.00) while maintaining a Buy rating.

Apogee Therapeutics to Participate in Upcoming June Conferences

Thu, 28 May 2026 16:01:00 -0400

SAN FRANCISCO and BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), today announced that members of management will participate at the following investor conferences.

Jefferies Global Healthcare Conference
Date: Wednesday, June 3, 2026
Fireside Time: 11:40 a.m. ET

Goldman Sachs 47th Annual Global Healthcare Conference
Date: Wednesday, June 10, 2026
Fireside Time: 9:20 a.m. ET

A live and archived webcast of the fireside chats will be available via the News & Events page in the Investors section of the Apogee Therapeutics website.

About Apogee
Apogee Therapeutics is a clinical-stage biotechnology company advancing

Apogee Therapeutics to Participate in Upcoming June Conferences

Thu, 28 May 2026 16:01:00 -0400

SAN FRANCISCO and BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), today announced that members of management will participate at the following investor conferences.

Jefferies Global Healthcare Conference
Date: Wednesday, June 3, 2026
Fireside Time: 11:40 a.m. ET

Goldman Sachs 47th Annual Global Healthcare Conference
Date: Wednesday, June 10, 2026
Fireside Time: 9:20 a.m. ET

A live and archived webcast of the fireside chats will be available via the News & Events page in the Investors section of the Apogee Therapeutics website.

About Apogee
Apogee Therapeutics is a clinical-stage biotechnology company advancing

Apogee Therapeutics to Participate in Upcoming June Conferences

Thu, 28 May 2026 16:01:00 -0400

SAN FRANCISCO and BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), today announced that members of management will participate at the following investor conferences.

Jefferies Global Healthcare Conference
Date: Wednesday, June 3, 2026
Fireside Time: 11:40 a.m. ET

Goldman Sachs 47th Annual Global Healthcare Conference
Date: Wednesday, June 10, 2026
Fireside Time: 9:20 a.m. ET

A live and archived webcast of the fireside chats will be available via the News & Events page in the Investors section of the Apogee Therapeutics website.

About Apogee
Apogee Therapeutics is a clinical-stage biotechnology company advancing

Apogee Therapeutics to Participate in Upcoming June Conferences

Thu, 28 May 2026 16:01:00 -0400

SAN FRANCISCO and BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), today announced that members of management will participate at the following investor conferences.

Jefferies Global Healthcare Conference
Date: Wednesday, June 3, 2026
Fireside Time: 11:40 a.m. ET

Goldman Sachs 47th Annual Global Healthcare Conference
Date: Wednesday, June 10, 2026
Fireside Time: 9:20 a.m. ET

A live and archived webcast of the fireside chats will be available via the News & Events page in the Investors section of the Apogee Therapeutics website.

About Apogee
Apogee Therapeutics is a clinical-stage biotechnology company advancing